Nader Francois

Insider

Director

Trades at: MRNA· TECX· TALS· XLRN· ALXN· PRVL

30D 90D 1Y

No open-market buys or sells in this period. The transactions below are grants, option exercises and gifts, which carry no market price.

Trading track record · all companies

Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.

Transactions · 90d

Open-market Buys Sells All types

No open-market buys or sells in this period — showing all activity (grants, exercises & gifts).

MRNA Grant·A
May 6, 26

Director

$0

10.6K sh · 2 lots

Own New
MRNA Exercise·M
Apr 30, 26

Director

$0

12.2K sh

Own New
MRNA Exercise·M
Apr 30, 26

Director

—

12.2K sh

Own +59%
TECX Grant·A
Apr 1, 26

Director

$0

20.4K sh

Own New

Date▾	Ticker	Role	Type	Shares	Own Δ	Price	Value
May 6, 2026	MRNA	Director	Grant A	10.6K2 lots	New	—	$0
Apr 30, 2026	MRNA	Director	Exercise M	12.2K	New	—	$0
Apr 30, 2026	MRNA	Director	Exercise M	12.2K	+59%	—	—
Apr 1, 2026	TECX	Director	Grant A	20.4K	New	—	$0

Buy Sell Non-market (grant · exercise · gift)

About Nader Francois

This profile aggregates every SEC Form 4 insider transaction reported by Nader Francois across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.